Biotechnology · Newport Beach, California, United States
$1.05
-1.78% (-$0.02)2026-07-09
Smart-Money SignalNeutral · 54/100— Insider open-market flow is flat over 90 days
Revenue$682.0K
Net Income-$5.0M
Gross Margin33.8%
Market Cap$2.0M
Price Performance
Historical data including institutional events
Company Profile
G
Graydon Bensler
CEO & Executive Director
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products.
The companyâs lead product includes EL-22, a first-in-class engineered probiotic approach to address obesityâs pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists.
It is also involved in the medical scientific research and development activities, as well as operates investment firms.
The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024.
PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.
